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P eutz-Jeghers (PJ) syndrome (PJS) is an autosomal dominant disease characterized by gastrointesti-
nal polyposis and pigmented spots on the skin of the 
fingertips and the mucous membranes of the lips and 
oral cavity [1-5].  The representative polyps seen in this 
syndrome are hamartomatous polyps with distinct 
pathologic features of extensive smooth muscle prolifer-
ation and an elongated arborized pattern of polyp for-
mation,  called PJ polyps [6].  PJ polyps occur most 
frequently in the jejunum,  followed by the ileum and 
duodenum,  and are occasionally found in the stomach,  
large intestine,  and even the nostrils.
By age 20 years,  patients with PJS have a 1-2% risk 
of developing malignancy in the gastrointestinal tract,  
pancreas,  breast,  testis,  ovaries,  or cervix.  Cancer 
prevalence increases to 30% by age 50 and to 80% by 
age 70.  In addition,  the incidence of intussusception 
due to small intestinal polyps is 15% by age 10 and 50% 
by age 20.  Thus,  surveillance for malignant diseases 
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The characteristics of gastric polyps in patients with Peutz-Jeghers (PJ) syndrome (PJS) have not been fully 
investigated.  The objective of this study was to reveal the endoscopic and pathologic findings of gastric polyps 
in patients with PJS.  We reviewed 11 patients with PJS treated at 6 institutions,  and summarized the endo-
scopic and pathologic features of their gastric polyps.  The polyps were mainly classified into 2 types: (i) soli-
tary or sporadic polyps > 5 mm,  reddish in color with a sessile or semi-pedunculated morphology (n = 9); and 
(ii) multiple sessile polyps ≤ 5 mm with the same color tone as the peripheral mucosa (n = 9).  Patients who 
underwent endoscopic mucosal resection for polyps > 5 mm were diagnosed with PJ polyps (n = 2),  whereas 
those who underwent biopsy were diagnosed with hyperplastic polyps.  Polyps ≤ 5 mm were pathologically 
diagnosed as fundic gland polyps or hyperplastic polyps.  This study revealed that patients with PJS present 
with 2 types of polyps in the stomach.  Endoscopic mucosal resection of polyps > 5 mm seems necessary for the 
pathologic diagnosis of PJ polyps.
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and polyps in the small intestine is vital in patients with 
PJS [3].  In this context,  prompt histopathologic diag-
nosis of PJ polyps and early intervention are essential.
In our prior study,  we retrospectively investigated 
14 Japanese patients with PJS who were treated at 6 hos-
pitals to determine the prevalence of cancer in this 
patient population [7].  During the review process,  we 
observed that gastric polyps were less frequently diag-
nosed as PJ polyps than were polyps in the small intes-
tine.  In addition,  to our knowledge,  the endoscopic 
characteristics of gastric polyps in patients with PJS 
have not been fully investigated.  In this study,  we 
review 11 patients with PJS and summarize the endo-
scopic and pathologic findings of their gastric polyps.
Methods
Letters of inquiry for patients with PJS were sent to 
five collaborating institutions from the Department of 
Gastroenterology and Hepatology,  Okayama University 
Graduate School of Medicine,  Dentistry and 
Pharmaceutical Sciences.  Patients with clinically diag-
nosed PJS were selected for inclusion in the study.  PJS 
was diagnosed when the patient met any of the follow-
ing clinical criteria: two or more histologically con-
firmed PJ polyps; any number of PJ polyps detected in 
a person whose family history included one close rela-
tive with PJS; characteristic mucocutaneous pigmenta-
tion in a person whose family history included one close 
relative with PJS; and any number of PJ polyps in a 
person who also had characteristic mucocutaneous pig-
mentation [8-10].  Finally,  15 patients diagnosed with 
PJS between January 1990 and January 2020 were iden-
tified and registered in the study.  Of these,  3 patients 
did not undergo esophagogastroduodenoscopy.  
Another patient underwent esophagogastroduodenos-
copy and histopathologic examination of the gastric 
polyps in a facility other than the collaborating institu-
tions.  Consequently,  we retrospectively reviewed and 
analyzed the endoscopic and histopathologic features of 
gastric polyps in the remaining 11 patients with PJS,  in 
addition to their clinical background characteristics.  Of 
the 11 patients examined in this study,  10 were also 
participants in our previous study [7].  
The present study was approved by the Ethics 
Committee of Okayama University Hospital (No. 2004-
019) and adhered to the Declaration of Helsinki.
Results
The characteristics of the enrolled patients and the 
endoscopic and pathologic features of their gastric pol-
yps are listed in Table 1.  The patient group included 7 
men and 4 women.  Mean age at diagnosis of PJS was 
27 years (range,  6-60 years).  We observed that the 
patients’ gastric polyps could be mainly classified into 2 
types: (i) solitary or sporadic polyps > 5 mm,  reddish 
in color with a sessile or semi-pedunculated morpholo-
gy; and (ii) multiple sessile polyps ≤ 5 mm with the 
same color tone as the peripheral mucosa.  In this study,  
10 patients who underwent esophagogastroduodenos-
copy had either or both types of polyps in the stom-
ach: 8 patients (72.7%) had both types,  1 patient 
(9.1%) had the first type of polyp only,  and 1 patient 
(9.1%) had the second type of polyp only.  The remain-
ing patient had no gastric polyps (9.1%).  No patients 
had pedunculated polyps in the stomach.
Among the 9 patients with solitary or sporadic polyps 
> 5 mm with a reddish color,  2 were histopathologically 
diagnosed by endoscopic mucosal resection; the diag-
nosis was PJ polyp in 1 patient (Fig. 1) and PJ polyp and 
hyperplastic polyp in 1 patient (Fig.2).  In the remaining 
7 patients with solitary or sporadic polyps > 5 mm with 
a reddish color,  histopathologic analysis was performed 
using endoscopic biopsy alone,  and the diagnosis was 
hyperplastic polyps in all these patients (Fig. 3A).  Based 
on the irregular architecture of the muscularis mucosae,  
a PJ polyp wads suspecte in 1patient (case 7).  However,  
a definitive diagnosis could not be made because exten-
sive smooth-muscle proliferation was not confirmed in 
the biopsy specimen.
Among the 9 patients with multiple polyps ≤ 5 mm 
with the same color tone as the peripheral mucosa 
(Figs. 3B and 4),  5 did not undergo histopathologic 
evaluation.  Biopsy sampling was performed in the 
remaining 4 patients,  and the diagnosis was fundic 
gland polyps in 3 patients,  and hyperplastic polyps in 
1 patient (Fig. 5).  Endoscopic findings other than pol-
yps in the stomach were atrophic gastritis in 3 patients,  
and gastric ulcer and atrophic gastritis in 1 patient.
Among the 11 patients with PJS,  3 had been taking 
proton pump inhibitors (Table 1).  Six patients under-
went tests to detect Helicobacter pylori infection: 2 were 
positive for H.  pylori,  while 4 were negative.  All but 1 
of the 11 patients (case 2) underwent both enteroscopy 
and colonoscopy in addition to esophagogastroduode-
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noscopy.  The enteroscopy methods used were double 
balloon enteroscopy alone (n = 5),  video capsule 
enteroscopy alone (n = 2),  both double-balloon and 
video capsule enteroscopy (n = 2),  and intraoperative 
enteroscopy during laparotomy (n = 1).  Locations of PJ 
polyps other than the stomach included the ileum 
(n = 6),  large intestine (n = 6),  jejunum (n = 5),  and 
duodenum (n = 2).  Mucocutaneous pigmentation was 
observed in 9 patients.  Patients with mucocutaneous 
pigmentation had multiple polyps ≤ 5 mm with the 
same color tone as the peripheral mucosa,  while the 
remaining 2 patients without mucocutaneous pigmen-
tation did not have polyps ≤ 5 mm.
Notably,  one of the patients (case 11) was misdiag-
nosed with familial adenomatous polyposis at the age of 
58.  The patient underwent multiple colonoscopies from 
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Fig.  1　 Images of a PJ polyp observed in case 2.  A reddish-color polypoid lesion >5 mm was identified in the gastric body (A).  
Pathologic analysis of the endoscopic mucosal resection specimen revealed smooth muscle fibers surrounding the lobulated clusters of 
gastric crypts (B & C),  which are characteristic features of PJ polyps.
A B C
D E F
Fig.  2　 Images of a PJ polyp and a hyperplastic polyp observed in case 1.  Two reddish-color polypoid lesions >5 mm were removed by 
endoscopic mucosal resection.  One polyp in the gastric body (A) showed an arborizing pattern of smooth muscle proliferation (B & C) and 
was diagnosed as a PJ polyp.  The other polyp was diagnosed as a hyperplastic polyp (D-F).
BA C
Fig.  3　 Images of gastric polyps observed in case 9.  Endoscopic biopsy was performed for a solitary polyp >5 mm with a reddish color,  
which was diagnosed as a hyperplastic polyp (A).  This patient had multiple polyps ≤5 mm with the same color tone as the peripheral 
mucosa (B).  Biopsy examination revealed that these gastric polyps were fundic gland polyps (C).
age 48-58,  and was diagnosed with polyps in the colon.  
Endoscopic mucosal resection was performed for the 
colonic polyps,  and the histopathologic diagnosis was 
adenoma.  Esophagogastroduodenoscopy performed 
when the patient was aged 58 years showed diffuse gas-
tric polyps ≤ 5 mm,  consistent with the typical endo-
scopic morphology of fundic gland polyps (Fig. 4).  In 
addition,  esophagogastroduodenoscopy and biopsy 
revealed adenoma of the duodenal papilla.  As diffuse 
gastric fundic gland polyps and adenoma of the duode-
nal papilla are well-known features of familial adeno-
matous polyposis,  we considered that familial adeno-
matous polyposis was the most probable diagnosis.  
However,  video capsule enteroscopy performed at age 
60 revealed pedunculated polyps in the small intestine.  
Polypectomy under double-balloon enteroscopy 
resulted in the histopathologic diagnosis of PJ polyps in 
the small intestine.  Physical examination revealed pig-
mentation on the palmoplantar skin of the lips.  Thus,  
PJS was finally diagnosed.
Discussion
Hamartomatous polyps in the gastrointestinal tract 
with extensive smooth muscle proliferation and an elon-
gated arborized pattern of polyp formation (i.e.,  PJ 
polyps) are one of the chief manifestations in patients 
with PJS [11 , 12].  PJ polyps are predominantly 
observed in the small intestine,  whereas it is known 
that polypoid lesions are often found in the stomach of 
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Fig.  4　 Images of gastric polyps observed in case 11.  The patient had adenomas in the duodenum and colon.  In addition,  
esophagogastroduodenoscopy revealed diffuse fundic gland polyps in the stomach. Because of the diffuse gastric fundic gland polyps and 
gastrointestinal adenomas,  the patient was initially misdiagnosed with familial adenomatous polyposis.
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Fig.  5　 Diagram showing polyp types in the stomach and their histopathological diagnosis.  PJ,  Peutz-Jeghers; EMR,  endoscopic 
mucosal resection.
patients with PJS.  Bartholomew et al.  reviewed 
182 patients with PJS,  and reported that polyps were 
most frequently found in the small intestine (96.2%),  
followed by the colon (29.1%),  rectum (24.2%),  and 
stomach (24.2%) [13].  In another study investigating 
222 Japanese patients with PJS,  the prevalence of gastric 
polyps was relatively high (48.6%),  whereas the small 
intestine was involved in 64.0%,  the colon in 53.2%,  
and the rectum in 32.0% of patients [14].  Although 
gastric polyps have been observed in not a few patients 
with PJS,  and the histopathology of gastric polyps in 
these patients has been explored in several reports,  to 
our knowledge,  the endoscopic features have not been 
sufficiently investigated thus far.  
In the present study,  polyps were observed in the 
stomachs of 10 out of 11 patients with PJS (90.9%).  The 
prevalence was higher than in previous articles,  which 
reported rates of 24.2% [13] and 48.6% [14].  We con-
sider that the difference was likely due to the surveil-
lance methods; endoscopy examinations were per-
formed in our study,  while barium-based fluoroscopy 
and macroscopic observation of the resected specimen 
were mainly performed in the previous reports,  which 
were conducted in the 1950s [13] and 1970s [14].  
Although proton pump inhibitor use is known to cause 
polypoid lesions in the stomach such as fundic gland 
polyps,  hyperplastic polyps,  multiple white and flat 
elevated lesions,  and cobblestone-like mucosa [15],  
only 3 of our patients had been taking proton pump 
inhibitors,  and 1 of them had no gastric polyps.  Thus,  
we consider that the high prevalence of gastric polyps 
observed in the present study was a manifestation of PJS 
itself.
Definitive diagnosis of PJ polyps was made in only 
2 patients who underwent endoscopic resection of gas-
tric polyps > 5 mm,  whereas this type of polyp was 
diagnosed as hyperplastic in the other patients who 
underwent endoscopic biopsy alone.  We speculate that 
endoscopic biopsies provide too small a sample for the 
histopathologic detection of extensive smooth-muscle 
proliferation,  a crucial feature for the diagnosis of PJ 
polyps.  Thus,  endoscopic resection of gastric polyps 
> 5 mm is required for the histopathologic identifica-
tion of PJ polyps.  However,  physicians should be aware 
that gastric polyps > 5 mm may be diagnosed as hyper-
plastic polyps even in endoscopically resected speci-
mens,  as seen in our case 1.  Therefore,  we consider 
that biopsy or resection of intestinal polyps,  rather than 
gastric polyps,  is more appropriate for the histopatho-
logic diagnosis of PJ polyps.
The presence or absence of mucocutaneous pigmen-
tation corresponded to the presence or absence of mul-
tiple polyps ≤ 5 mm with the same color tone as the 
peripheral mucosa in the stomach.  Nine patients with 
mucocutaneous pigmentation had polyps ≤ 5 mm.  
Conversely,  2 patients without mucocutaneous pig-
mentation did not have polyps ≤ 5 mm.  These results 
suggest that mucocutaneous pigmentation predicts con-
comitant gastric polyps ≤ 5 mm.  However,  a relatively 
small number of patients were included in this study,  
and further studies are needed to investigate the rela-
tionship between clinical manifestation and types of 
gastric polyps.
Another important implication of the present study 
is that multiple fundic gland polyps can be found in the 
stomach of patients with PJS,  and these features may 
lead to a misdiagnosis.  As previously described,  fundic 
gland polyps are the most common gastric polyps in 
patients with familial adenomatous polyposis [16].  
Thus,  PJS patients with multiple fundic gland polyps 
may be misdiagnosed with familial adenomatous pol-
yposis unless they have pedunculated PJ polyps in the 
gastrointestinal tract.  The surveillance protocols differ 
between patients with the 2 conditions because they are 
characterized by risk for malignant progression of dif-
ferent tumors: most patients with familial adeno-
matous polyposis develop colorectal cancer if the polyps 
are left untreated,  whereas patients with PJS have an 
increased risk of developing cancers of various organs 
such as the breast,  colorectum,  pancreas,  stomach,  
testicles,  ovaries,  lung,  and cervix [17 , 18].  In this 
context,  endoscopic detection and pathological diagno-
sis of PJ polyps and physical examinations of mucocu-
taneous pigmentations are important to differentiate PJS 
from familial adenomatous polyposis.  Correct diagno-
sis is crucial for the appropriate management of patients 
with gastrointestinal polyposis,  as well as their relatives,  
since both PJS and familial adenomatous polyposis are 
autosomal dominant genetic disorders.
This study had several limitations.  First,  although 
we recruited patients from six institutions,  only 11 were 
enrolled owing to the rarity of this disease.  A nation-
wide survey of patients with PJS is required to reveal the 
true prevalence and distinctive features of gastric polyps 
in patients with this disease.  Second,  the presence of 
STK11/LKB1 germline mutations,  which are specific 
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for PJS,  was not investigated.  In Japan,  unfortunately,  
genetic testing is virtually unavailable in clinical set-
tings,  as it is not covered by health insurance.
In conclusion,  we retrospectively investigated the 
endoscopic and histopathologic features of gastric pol-
yps in 11 patients with PJS.  We found 2 types of polyps 
in the stomach: (i) solitary or sporadic polyps > 5 mm 
and reddish in color with a sessile or semi-peduncu-
lated morphology; and (ii) multiple sessile polyps 
≤ 5 mm with the same color tone as the peripheral 
mucosa.  Both hyperplastic and PJ polyps were included 
in the first type of polyps,  and PJ polyps were diag-
nosed only when the polyps were endoscopically 
resected.  Thus,  endoscopic resection of gastric polyps 
> 5 mm is required for the histopathologic identifica-
tion of PJ polyps.  Fundic gland polyps and hyperplastic 
polyps were included in the second type of polyps,  and 
care should be taken not to confuse the multiple fundic 
gland polyps of PJS with those of familial adenomatous 
polyposis.  We believe that a better understanding of the 
endoscopic features of gastric polyps in patients with 
PJS will lead to accurate and prompt diagnosis.
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